Adlai Nortye (ANL) Current Assets (2022 - 2025)
Adlai Nortye (ANL) reported Current Assets of $26.9 million for Q4 2025, down 58.02% year-over-year from $64.1 million in Q4 2024, and down 58.93% on a QoQ basis from $65.5 million in Q2 2025.
Adlai Nortye (ANL) has 4 years of Current Assets data on file, last reported at $26.9 million in Q4 2025.
- Quarterly Current Assets fell 58.02% year-over-year to $26.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.9 million (down 58.02% YoY) and the FY2025 annual result came in at $26.9 million, down 58.02% from the prior year.
- Current Assets retreated to $26.9 million in Q4 2025 per ANL's latest filing, from $65.5 million in the prior quarter.
- Across five years, Current Assets topped out at $101.2 million in Q4 2023 and bottomed at $26.9 million in Q4 2025.
- The 4-year median for Current Assets is $65.9 million (2022), against an average of $70.7 million.
- The widest annual swing landed in 2023, when Current Assets surged 52.63%; it then plunged 58.02% in 2025.
- Tracing ANL's Current Assets over 4 years: stood at $66.3 million in 2022, then soared by 52.63% to $101.2 million in 2023, then tumbled by 36.69% to $64.1 million in 2024, then sank by 58.02% to $26.9 million in 2025.
- Per Business Quant, the three latest ANL Current Assets figures stand at $26.9 million (Q4 2025), $65.5 million (Q2 2025), and $64.1 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 18.21 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 26.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.89 Mn |
| Jun 30, 2025 | 65.48 Mn |
| Dec 31, 2024 | 64.06 Mn |
| Jun 30, 2024 | 100.28 Mn |
| Dec 31, 2023 | 101.20 Mn |
| Dec 31, 2022 | 66.30 Mn |